The Advancement of Patient Randomization and Trial Supply Management Technology for COVID-19 Trials and Beyond
About this webinar
The clinical trial environment was already evolving at a rapid pace before the presence of COVID-19, but now speed and efficiency are paramount. Expectations and performance of an Interactive Response Technology (IRT) partner have now intensified as sponsors require a shorter time to go live, while requiring advancements in risk mitigation and ensuring the drug can get to the patient.
In this insightful webinar, we will present a look at current trial challenges that sponsors are facing, how novel IRT products are actively helping sponsors in their fight against COVID-19 and offer practical tips that will keep your study conduct in compliance and progressing amidst the pandemic.
Who should attend
- Study Leads/Managers
- Vendor Managers
- IRT Experts
- Medication/Supply Managers
- Systems Validation Personnel
What you will learn
- Understanding the impact of today’s environment on clinical trials and their patients
- Introduction of novel IRT product designed precisely for clinical situations where speed and precision are paramount
- Practical tips for streamlining your trials and ensuring drug delivery while remaining compliant
Featured Speakers
Mike Hutton
Mike Hutton graduated from University of East Anglia with a PhD in biochemistry and spent 10 years in scientific and medical research in Birmingham, Cambridge and Norwich, England. Hutton has now been with Almac over 17 years working in various roles of increasing responsibility, from project management to operational management. He is now in a tactical commercial role, where he oversees several key clients along with developing new and exciting business in EU and beyond with Almac’s leading Interactive Response Technology.
Brian Mullin
Brian Mullin holds a Bachelor of Engineering in product design and manufacturing from Loughborough University in England. After spending 12 years in the telecommunications industry in various roles including mechanical design, project management and service delivery, he began his next chapter with Almac Clinical Technologies. Here, Mullin has enjoyed developing and increasing efficiency in IRT design and project management for the past 11 years. Currently, Mullin leads the UK Design Management Team at Almac Clinical Technologies.
Partner for this event
Almac Clinical Technologies
Almac Clinical Technologies: For over 20 years and more than 3,000 clinical trials, Almac Clinical Technologies have been at the forefront of innovation for technology-enabled solutions in the highly-regulated biopharmaceutical industry. Almac Clinical Technologies are the only Interactive Response Technology software partner who were successfully audited by the FDA.
Related webinars
More from Almac.
IVD Study Steps for Success: Safety and Quality of Global IVD Clinical Performance Studies
Biomarker Solutions for Steatotic Liver Disease: Enabling Better Insights into MASH/MASLD Biology
Overcoming Sample Management Challenges in Clinical Trials with End-to-End Solutions
Overcoming EU IVDR Challenges When Using Clinical Trial Assays to Accelerate Global CDx Trials
Interactive Response Technology User Support: Where eClinical Software and a Site-Centric Mindset Converge
Leveraging IRT User Acceptance Testing Strategy to Navigate Clinical Trial Complexity
Clinical Trial Assay Development for Precision Medicine: Insights from Pharma & Diagnostics Experts
Care is Critical: Lessons Learned from Clinical Trial Inspections
Biomarker Discovery from Gene Expression: Challenges and Solutions for Success
Clinical Trial Assay Development & Validation – Strategies for Success
The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials
Post-Brexit Solutions: The Northern Ireland Protocol and the Opportunity That Exists to Create A Robust Clinical Supply Chain